Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency

Clin Endocrinol (Oxf). 2000 Nov;53(5):645-7. doi: 10.1046/j.1365-2265.2000.01044.x.

Abstract

The respective contributions of pituitary and placental GH to circulating IGF-I in pregnant women have not been well established. We measured the serum concentrations of placental growth hormone (PGH) and IGF-I in a woman with pit-1 deficiency before, during and after pregnancy, resulting in the birth of a healthy child (not pit-1 deficient). Both PGH and IGF-I concentrations were below the assay detection limit before and after pregnancy. During pregnancy, PGH and IGF-I levels increased steadily; the concentrations of PGH and IGF-I in late pregnancy were comparable with levels previously measured in normal pregnancies. PGH and IGF-I concentrations were strongly correlated throughout pregnancy (r = 0.90; P = 0.002). PGH was undetectable in cord serum, whilst the IGF-I concentration was within the normal range. The findings of this case study corroborate the notion that PGH is the prime regulator of maternal serum IGF-I during pregnancy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • DNA-Binding Proteins / deficiency*
  • Female
  • Fetal Blood / chemistry
  • Humans
  • Hypothyroidism / complications
  • Hypothyroidism / drug therapy
  • Immunoradiometric Assay
  • Insulin-Like Growth Factor I / analysis*
  • Pituitary Hormones / genetics*
  • Placental Hormones / blood*
  • Pregnancy
  • Pregnancy Complications / metabolism*
  • Thyroxine / therapeutic use
  • Transcription Factor Pit-1
  • Transcription Factors / deficiency*

Substances

  • DNA-Binding Proteins
  • POU1F1 protein, human
  • Pituitary Hormones
  • Placental Hormones
  • Transcription Factor Pit-1
  • Transcription Factors
  • Insulin-Like Growth Factor I
  • Thyroxine